Philippine studio Viva Communications has acquired the rights to remake the Indonesian film 2nd Miracle in Cell No. 7, marking the first time an Indonesian film will be officially remade for the Philippine market. The adaptation is set to premiere on December 25 as part of the Metro Manila Film Festival (MMFF), a major annual event in the Philippines that showcases locally produced films. The original Miracle in Cell No. 7 was released in Indonesia in 2017 and was based on a true story about a man who was wrongfully imprisoned and later exonerated. It became a commercial success in Indonesia, grossing over 1.2 billion rupiah at the box office. The Philippine version of the film will be directed by Jason Paul Llorenzo and will feature a cast including John Arcilla, Judd Applegarth, and Gian D’Angelo. The film will be released in both 2D and 3D formats, offering viewers a choice of viewing experiences. The MMFF is a significant event in the Philippine film industry, typically held in December and drawing a large audience of film enthusiasts and professionals. It is considered one of the most important film festivals in the country, highlighting the best of local cinema. This remake underscores the growing interest in cross-border film collaborations and the appeal of true-story-based dramas in the region. The Philippine version is expected to be released in multiple formats and will be shown in theaters across the country, aiming to reach a wide audience. By adapting an Indonesian film for the Philippine market, Viva Communications is tapping into a successful narrative that has already resonated with audiences in Indonesia. The Metro Manila Film Festival not only celebrates local talent but also serves as a platform for new films to gain visibility and critical acclaim. As the festival continues to grow in influence, it plays a crucial role in shaping the landscape of Philippine cinema. The upcoming release of 2nd Miracle in Cell No. 7 is expected to be a highlight of the event, drawing attention from both local and international audiences.